| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Analog Devices | 5 | Q2 2014 | 6.5% |
| GlaxoSmithKline | 5 | Q2 2014 | 3.5% |
| SPDR Index Shs | 5 | Q2 2014 | 3.8% |
| iShares Trust | 5 | Q2 2014 | 3.5% |
| SPDR Index Shs | 5 | Q2 2014 | 3.0% |
| Vanguard ETF | 5 | Q2 2014 | 3.3% |
| JP Morgan Chase | 5 | Q2 2014 | 3.6% |
| Vanguard ETF | 5 | Q2 2014 | 2.9% |
| SPDR Index Shs | 5 | Q2 2014 | 2.3% |
| SPDR Index Shs | 5 | Q2 2014 | 2.4% |
View Long Wharf Investors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2014-08-04 |
| 13F-HR | 2014-04-29 |
| 13F-HR | 2014-02-07 |
| 13F-HR | 2013-11-05 |
| 13F-HR | 2013-08-06 |
| 13F-HR | 2013-04-25 |
| 13F-HR | 2013-01-24 |
| 13F-HR | 2012-10-30 |
| 13F-HR | 2012-07-20 |
| 13F-HR | 2012-04-25 |
View Long Wharf Investors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.